SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma

被引：0
|
作者：
Michael E. Wechsler
Gene Colice
Janet M. Griffiths
Gun Almqvist
Tor Skärby
Teresa Piechowiak
Primal Kaur
Karin Bowen
Åsa Hellqvist
May Mo
Esther Garcia Gil
机构：
[1] National Jewish Health,Respiratory & Immunology
[2] BioPharmaceuticals R&D,Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology
[3] AstraZeneca,Late Respiratory & Immunology
[4] BioPharmaceuticals R&D,Development Operations
[5] AstraZeneca,Biometrics, Late Respiratory & Immunology
[6] BioPharmaceuticals R&D,Biometrics, Late Respiratory & Immunology
[7] AstraZeneca,Global Medical Respiratory
[8] BioPharmaceuticals R&D,undefined
[9] AstraZeneca,undefined
[10] Amgen,undefined
[11] BioPharmaceuticals R&D,undefined
[12] BioPharmaceuticals R&D,undefined
[13] BioPharmaceuticals R&D,undefined
[14] AstraZeneca,undefined
来源：
Respiratory Research | / 21卷
关键词：
Alarmin; Asthma; Asthma control; Exacerbation; Epithelial; Oral corticosteroids; SOURCE; Steroid-sparing; Tezepelumab; TSLP;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma
    Wechsler, Michael E.
    Colice, Gene
    Griffiths, Janet M.
    Almqvist, Gun
    Skarby, Tor
    Piechowiak, Teresa
    Kaur, Primal
    Bowen, Karin
    Hellqvist, Asa
    Mo, May
    Garcia Gil, Esther
    RESPIRATORY RESEARCH, 2020, 21 (01)
  • [2] NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
    Andrew Menzies-Gow
    Gene Colice
    Janet M. Griffiths
    Gun Almqvist
    Sandhia Ponnarambil
    Primal Kaur
    Gennaro Ruberto
    Karin Bowen
    Åsa Hellqvist
    May Mo
    Esther Garcia Gil
    Respiratory Research, 21
  • [3] NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
    Menzies-Gow, Andrew
    Colice, Gene
    Griffiths, Janet M.
    Almqvist, Gun
    Ponnarambil, Sandhia
    Kaur, Primal
    Ruberto, Gennaro
    Bowen, Karin
    Hellqvist, Asa
    Mo, May
    Garcia Gil, Esther
    RESPIRATORY RESEARCH, 2020, 21 (01)
  • [4] Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study
    Wechsler, Michael E.
    Menzies-Gow, Andrew
    Brightling, Christopher E.
    Kuna, Piotr
    Korn, Stephanie
    Welte, Tobias
    Griffiths, Janet M.
    Salapa, Kinga
    Hellqvist, Asa
    Almqvist, Gun
    Lal, Harbans
    Kaur, Primal
    Skarby, Tor
    Colice, Gene
    LANCET RESPIRATORY MEDICINE, 2022, 10 (07): : 650 - 660
  • [5] DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma
    Andrew Menzies-Gow
    Sandhia Ponnarambil
    John Downie
    Karin Bowen
    Åsa Hellqvist
    Gene Colice
    Respiratory Research, 21
  • [6] DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma
    Menzies-Gow, Andrew
    Ponnarambil, Sandhia
    Downie, John
    Bowen, Karin
    Hellqvist, Asa
    Colice, Gene
    RESPIRATORY RESEARCH, 2020, 21 (01)
  • [7] A randomized, double-blind, parallel-group, placebo-controlled Phase 3 trial to evaluate efficacy and safety of ocrelizumab in PPMS
    Montalban, Xavier
    Hemmer, Bernhard
    Rammohan, Kottil W.
    Giovannoni, Gavin
    De Seze, Jerome
    Bar-Or, Amit
    Arnold, Douglas L.
    Sauter, Annette
    Masterman, Donna
    Fontoura, Paulo
    Chin, Peter
    Garren, Hideki
    Wolinsky, Jerry S.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 17 - 17
  • [8] A multicenter, randomized, double-blind, placebo-controlled trial of high-dose intravenous immunoglobulin for oral corticosteroid-dependent asthma
    Kishiyama, JL
    Valacer, D
    Cunningham-Rundles, C
    Sperber, K
    Richmond, GW
    Abramson, S
    Glovsky, M
    Stiehm, R
    Stocks, J
    Rosenberg, L
    Shames, RS
    Corn, B
    Shearer, WT
    Bacot, B
    DiMaio, M
    Tonetta, S
    Adelman, DC
    CLINICAL IMMUNOLOGY, 1999, 91 (02) : 126 - 133
  • [9] Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study (vol 10, pg 650, 2022)
    Wechsler, M. E.
    Menzies-Gow, A.
    Brightling, C. E.
    LANCET RESPIRATORY MEDICINE, 2022, 10 (05): : E73 - E73
  • [10] CORTICOSTEROID TAPERING FOLLOWING EXACERBATION OF ASTHMA - A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL
    LEDERLE, FA
    PLUHAR, RE
    JOSEPH, AM
    NIEWOEHNER, DE
    CLINICAL RESEARCH, 1987, 35 (06): : A928 - A928
12345